Literature DB >> 16836575

The National Marrow Donor Program with emphasis on the early years.

Jeffrey McCullough1, Herbert A Perkins, John Hansen.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16836575     DOI： 10.1111/j.1537-2995.2006.00842.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  9 in total

1.  Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust.

Authors:  David Stroncek; Jeffrey McCullough
Journal:  Expert Rev Hematol       Date:  2012-02       Impact factor: 2.929

Review 2.  Stem cells and regenerative medicine: accomplishments to date and future promise.

Authors:  Karim Y Helmy; Shyam A Patel; Kimberly Silverio; Lillian Pliner; Pranela Rameshwar
Journal:  Ther Deliv       Date:  2010-11

3.  Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Mary Joseph Acevedo; Jennifer S Wilder; Sharon Adams; Joie Davis; Corin Kelly; Dianne Hilligoss; Ellen Carroll; Bazetta Blacklock-Schuver; Kristen Cole; Elizabeth M Kang; Amy P Hsu; Christopher G Kanakry; Dimana Dimitrova; Jennifer A Kanakry
Journal:  Biol Blood Marrow Transplant       Date:  2019-04-12       Impact factor: 5.742

Review 4.  Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

Authors:  Robert R Jenq; Marcel R M van den Brink
Journal:  Nat Rev Cancer       Date:  2010-02-19       Impact factor: 60.716

5.  Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.

Authors:  Zachariah A McIver; Jason M Grayson; Benjamin N Coe; Jacqueline E Hill; Gregory A Schamerhorn; Tymish Y Ohulchanskyy; Michelle K Linder; Kellie S Davies; Roy S Weiner; Michael R Detty
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

6.  Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants.

Authors:  Richard J O'Reilly; Ekaterina Doubrovina; Deepa Trivedi; Aisha Hasan; Wouter Kollen; Guenther Koehne
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.

Authors:  Alexander Dew; Demetria Collins; Andrew Artz; Elizabeth Rich; Wendy Stock; Kate Swanson; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2008-08       Impact factor: 5.742

Review 8.  The HLA system: genetics, immunology, clinical testing, and clinical implications.

Authors:  Sung Yoon Choo
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

9.  Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant.

Authors:  Monzr M Al Malki; Ni-Chun Tsai; Joycelynne Palmer; Sally Mokhtari; Weimin Tsai; Thai Cao; Haris Ali; Amandeep Salhotra; Shukaib Arslan; Ibrahim Aldoss; Nicole Karras; Chatchada Karanes; Jasmine Zain; Samer Khaled; Anthony Stein; David Snyder; Guido Marcucci; Stephen J Forman; Ryotaro Nakamura
Journal:  Blood Adv       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.